Federal contract award
75F40123F19094
TO OBTAIN BIOINFORMATICS SERVICES TO SUPPORT THE DEVELOPMENT OF AN INTERNAL BIOINFORMATICS VALIDATION PIPELINE TARGETING NEOANTIGEN CANCER VACCINE DEVELOPMENT. THESE EFFORTS WILL SUPPORT THE REGULATORY PROGRAM OF THE DCT IN OTP/CBER/FDA.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40119D10015 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $254.0K |
| Current contract value | $254.0K |
| Potential contract value / ceiling | $254.0K |
| Start date | Aug 11, 2023 |
| Current end date | Sep 12, 2025 |
| Potential end date | Sep 12, 2025 |
| Latest award activity | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 11, 2026 | P00003 | $-90.5K | TO OBTAIN BIOINFORMATICS SERVICES TO SUPPORT THE DEVELOPMENT OF AN INTERNAL BIOINFORMATICS VALIDATION PIPELINE TARGETING NEOANTIGEN CANCER VACCINE DEVELOPMENT. THESE EFFORTS WILL SUPPORT THE REGULATORY PROGRAM OF THE DCT IN OTP/CBER/FDA. |
| Apr 1, 2025 | P00002 | $0 | EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT |
| May 7, 2024 | P00001 | $172.2K | TO OBTAIN BIOINFORMATICS SERVICES TO SUPPORT THE DEVELOPMENT OF AN INTERNAL BIOINFORMATICS VALIDATION PIPELINE TARGETING NEOANTIGEN CANCER VACCINE DEVELOPMENT. THESE EFFORTS WILL SUPPORT THE REGULATORY PROGRAM OF THE DCT IN OTP/CBER/FDA. |
| Aug 11, 2023 | 0 | $172.2K | TO OBTAIN BIOINFORMATICS SERVICES TO SUPPORT THE DEVELOPMENT OF AN INTERNAL BIOINFORMATICS VALIDATION PIPELINE TARGETING NEOANTIGEN CANCER VACCINE DEVELOPMENT. THESE EFFORTS WILL SUPPORT THE REGULATORY PROGRAM OF THE DCT IN OTP/CBER/FDA. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.